Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

CrossWork's Venture Fund Named "Best Pre-IPO Fund"; Expanding Life Sciences Advisory Board With Accomplished Medical Doctors, Scientists, And Industry Executives


News provided by

CrossWork Pre-IPO Fund

Apr 19, 2022, 13:00 ET

Share this article

Share toX

Share this article

Share toX

CrossWork.us Pre-IPO Fund
CrossWork.us Pre-IPO Fund

CrossWork's selective late-stage pre-IPO fund is adding a small number of highly accomplished senior medical doctors, biotech professionals, pharmaceutical executives, medical device executives, and other life sciences industry leaders to its specialist life sciences advisory board. CrossWork has a particular interest in senior medical doctors that serve on corporate advisory boards or have an interest therein. In addition to targeting cutting-edge medical investments including CRISPR gene editing and preventative medicine, CrossWork targets traditional pre-IPO investments in highly-established companies like SpaceX, Stripe, TikTok (Byte Dance), Discord, etc. Rather than focus on riskier, smaller startup companies, CrossWork focuses primarily on companies that already have revenues or valuation of over $1 billion.

NEW YORK, April 19, 2022 /PRNewswire-PRWeb/ -- While CrossWork is a multi-sector, late-stage, pre-IPO fund with roots in technology sector investing it is building out a significant life sciences investment capability. Because senior medical doctors live and breathe on the cutting edge of life sciences, and often have critical direct patient feedback, CrossWork is making a particularly strong push to add accomplished senior doctors to its advisory board. Highly accomplished / senior doctors that serve (or are interested in serving) on corporate advisory boards or who have participated or invested in the venture capital or pre-IPO spaces can schedule a time to have a preliminary discussion with CrossWork's investment team at meetmidas.crosswork.us

Advisory board members provide strategic insights from a real-world point of view into the financial investments that CrossWork's fund considers. They can exclude themselves, or are excluded from any potentially conflicting discussions. A recent addition to CrossWork's advisory board, Dr. Moti Ramgopal, a medical doctor and senior leader in medicine as well as a senior member of the Cleveland Clinic health system informally provided his first-hand general view of the pace of development of CRISPR gene-editing technologies for the treatment of diseases. These types of unique insights help the CrossWork team shape its thoughts around life sciences sector focus and life sciences investments.

CrossWork’s pre-IPO VC fund is selectively expanding its life sciences board. Highly accomplished doctors that serve (or are interested in serving) on corporate boards or who have participated or invested in venture capital can schedule a preliminary call with CrossWork at meetmidas.crosswork.us

Post this

CrossWork provides advisory board members with complimentary equity allocations in some of the companies in which it holds equity stakes. CrossWork takes great care of its advisory board members who include a former CFO of Yahoo, former CEO of Spirit Airlines, a Shark Tank judge and the co-founder of WordPress. Recent speakers at CrossWork Advisory board meetings include Mohan Ananda, the founder of Stamps.com (acquired after reaching $6 billion market value) and Charles Bisgaier, himself an advisory board member, the co-developer of Lipitor - a top-selling drug of all time that reached $13 billion a year in sales at its peak.

CrossWork's fund was recently announced "Best Pre-IPO Fund-US" in connection with the 2021 M&A Awards. CrossWork's Midas Pre-IPO Fund investors and advisors include current and former employees of Facebook, Yahoo, LinkedIn, Morgan Stanley, Goldman Sachs, and other executives. The team is one of the most experienced in the pre-IPO space having participated in IPOs since the 1990s and having been involved in pre-IPO opportunities including Facebook, Twitter, LinkedIn, and many more.

Overall market pre-IPO returns have been strong with the 2020 IPO cohort returning a whopping 117% over approx. 2 years for those companies that were valued at over $1 billion in their last institutional funding round prior to IPO.

According to the publisher of the 2021 M&A Awards "Long-term relationships, innovation, persistence, integrity, optimization, and clear results are all pillars upon which CrossWork.us has been built. Leveraging unique access to, hard-to-access pre-IPO investment opportunities, CrossWork is building a coveted portfolio of companies in a sector that produced market returns of over 117% in the two years ended 2020. Its investors and advisors include numerous high-profile leaders from a broad range of industries. We are hopeful that investment access to a CrossWork fund will not only be reserved exclusively for ultra-high net worth investors and their family offices. According to a Crunchbase article, late-stage investors in pre-IPO unicorns were rewarded with 2020 IPO returns of over 117% over a median time frame of just over 2 years. M&A exit returns were even higher than IPO returns. One of the things that makes CrossWork's Midas fund stand out from other funds, is that it employs powerful risk reduction and return enhancements that cannot be found elsewhere. It runs a mid-stage accelerator and allocates a portion of the stock from accelerator companies on a complimentary basis to Midas fund investors. This increases the fund's return profile significantly while also reducing its risk profile. CrossWork.us stays ahead of its competitors through this and other ground-breaking pre-IPO investment strategies."

About CrossWork

CrossWork.us named "2021 Best Pre-IPO VC Fund Manager – USA". CrossWork manages the CrossWork Midas pre-IPO fund. CrossWork's Midas fund investors and advisors include current and former employees of Facebook, Yahoo, LinkedIn, Morgan Stanley, Goldman Sachs and other successful executives. CrossWork's Midas fund invests in grade A pre-IPO opportunities and employs powerful risk reduction and return enhancements not available in other funds.

Invest In CrossWork's Midas Fund: midasdocs.crosswork.us

Meet With A CrossWork Professional: meetmidas.crosswork.us

A CrossWork Midas investment may only be purchased by accredited investors. Further, past results do not guarantee future results. See risks at https://crosswork.us/risk-factors-disclosures-2/

Important: Investments in private companies are illiquid, carry increased risks and may result in losses. Past results are no guarantee of future performance. Investment strategies referenced herein may not be exactly replicable. No financial advice is provided herein. Please seek financial advice to determine your suitability for the matters herein. This is not an offering document and no offer is made, implied, or may be assumed by virtue thereof. IRA accounts may have fees charged by the IRA custodian. The information herein is for accredited investors, i.e. only those with an annual income over $200k ($300k combined with a spouse) or net worth of $1 million either alone or combined with a spouse. Also includes certain family offices, trusts, entities, and institutions with more than $5 million in assets.

Contacts:

Investor Relations
Las Vegas, Nevada
CrossWork.us
(213) 327-5920
[email protected]

Media Contact

Steven Smith, CrossWork Pre-IPO Fund, 1 2133275920, [email protected]

Twitter, LinkedIn, Facebook

SOURCE CrossWork Pre-IPO Fund

Modal title

117% Returns Over 2 Years For 2020 IPO Cohort Of Companies Worth Over $1 Billion
117% Returns Over 2 Years For 2020 IPO Cohort Of Companies Worth Over $1 Billion
117% Returns Over 2 Years For 2020 IPO Cohort Of Companies Worth Over $1 Billion

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.